For the second quarter ended June 30, Novartis' $10.73 billion in sales was spurred in part by an 11.9 percent jump in sales in its Consumer Health operation, which climbed to $1.53 billion. The division's performance was led by CIBA Vision, which saw improvements over the same period last year ...
Buying a membership today will give you:
To continue reading this article register now.